These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8935749)

  • 1. Correction of neutropenia following treatment with granulocyte colony-stimulating factor results in a decreased frequency of infections in Shwachman's syndrome.
    van der Sande FM; Hillen HF
    Neth J Med; 1996 Mar; 48(3):92-5. PubMed ID: 8935749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of neutropenia in Shwachman's syndrome with granulocyte growth factor (G-CSF)].
    Grill J; Bernaudin F; Dresch C; Lemerle S; Reinert P
    Arch Fr Pediatr; 1993 Apr; 50(4):331-3. PubMed ID: 7691045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemia complicating bone marrow hypoplasia in an adult with Shwachman's syndrome.
    Seymour JF; Escudier SM
    Leuk Lymphoma; 1993 Dec; 12(1-2):131-5. PubMed ID: 7512852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of effects of KRN8601 (rhG-CSF) on neutropenia].
    Nakahata T; Akabane T; Miura A; Tada K; Uzuka Y; Hayashi T; Shibata A; Shiko S; Okuni M; Urabe A
    Rinsho Ketsueki; 1992 Feb; 33(2):123-32. PubMed ID: 1378911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rhG-CSF for Shwachman's syndrome.
    Adachi N; Tsuchiya H; Nunoi H; Higuchi S; Akaboshi I; Chikazawa S
    Lancet; 1990 Nov; 336(8723):1136. PubMed ID: 1700246
    [No Abstract]   [Full Text] [Related]  

  • 6. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
    Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
    J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rational therapy with G-CSF and GM-CSF].
    Link H; Herrmann F; Welte K; Aulitzky WE; Ganser A; Kern WV; Meyer P; Schrappe M; Schmoll HJ; Werdan K
    Med Klin (Munich); 1994 Aug; 89(8):429-41. PubMed ID: 7526144
    [No Abstract]   [Full Text] [Related]  

  • 8. Human granulocyte colony-stimulating factor (rHuG-CSF) for treatment of neutropenia in Shwachman syndrome.
    Ventura A; Dragovich D; Luxardo P; Zanazzo G
    Haematologica; 1995; 80(3):227-9. PubMed ID: 7545636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [G-CSF in patients with lupus-associated neutropenia and infections].
    Schwab UM; Harten P; Zeuner RA; Külper M; Euler HH
    Z Rheumatol; 1996; 55(3):174-9. PubMed ID: 8768147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemopoietic colony-forming cells in Shwachman's syndrome.
    Suda T; Mizoguchi H; Miura Y; Kubota K; Ikuta K; Sasaki H; Nagao T
    Am J Pediatr Hematol Oncol; 1982; 4(2):129-33. PubMed ID: 7114396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
    Glaspy JA; Baldwin GC; Robertson PA; Souza L; Vincent M; Ambersley J; Golde DW
    Ann Intern Med; 1988 Nov; 109(10):789-95. PubMed ID: 2461131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Integration of G-CSF in prevention and therapy of neutropenic fever].
    Siegmund R; Illiger HJ
    Med Klin (Munich); 1996 Feb; 91(2):82-8. PubMed ID: 8850103
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New, in Austria registered specialty drugs. Neupogen (G-CSF)].
    Wien Klin Wochenschr; 1991; 103(21):661-6. PubMed ID: 1722934
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
    Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
    Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential use of G-CSF and GM-CSF after heart-lung transplantation.
    Ippoliti G; Negri M; Rovati B; Grossi P; Viganó M
    J Heart Lung Transplant; 1997 Apr; 16(4):473-5. PubMed ID: 9154962
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
    Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA
    J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulopoiesis in Shwachman's syndrome (pancreatic insufficiency and bone marrow dysfunction).
    Saunders EF; Gall G; Freedman MH
    Pediatrics; 1979 Oct; 64(4):515-9. PubMed ID: 315048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.